CDD-2211 is a STK33 inhibitor, with a K d of 0.018 nM and an IC 50 of 5 nM. CDD-2211 has relatively weak inhibitory effects on off-target kinases, with IC 50 values of 115 nM for CLK1 , 48 nM for CLK2 , 187 nM for CLK4 , and 78 nM for RET . CDD-2211 can be used for the study of contraception.
Products | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Others | Products > Signaling Pathways > STK33 | Products > Signaling Pathways > RET
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.